Cargando…
Desensitization using imlifidase and EndoS enables chimerism induction in allosensitized recipient mice
Mixed hematopoietic chimerism induction as a way to foster tolerance to donor organs in recipients who have been sensitized to donor antigens is challenging. Donor‐specific antibodies (DSA) are a dominant barrier toward successful donor bone marrow engraftment. Although desensitization methods are r...
Autores principales: | Lin, Jiaxin, Boon, Louis, Bockermann, Robert, Robertson, Anna‐Karin, Kjellman, Christian, Anderson, Colin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496317/ https://www.ncbi.nlm.nih.gov/pubmed/32185855 http://dx.doi.org/10.1111/ajt.15851 |
Ejemplares similares
-
Imlifidase-generated Single-cleaved IgG: Implications for Transplantation
por: Bockermann, Robert, et al.
Publicado: (2021) -
Outcomes at 3 years posttransplant in imlifidase‐desensitized kidney transplant patients
por: Kjellman, Christian, et al.
Publicado: (2021) -
Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023) -
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021) -
Imlifidase for the treatment of anti‐HLA antibody‐mediated processes in kidney transplantation
por: Huang, Edmund, et al.
Publicado: (2021)